Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 23
Phase 31

Trial Status

Completed2
Other4

Role Distribution

Principal Investigator4
Other Roles2
PI Rate67%

Activity Timeline

Clinical Trials (6)

NCT06373406Phase 1/2Active Not Recruiting
A Study of MHB036C for Advanced Solid Tumor
Advanced Solid Tumor
PrincipalinvestigatorStart date: 2023-05-26
NCT05078931Phase 2Active Not Recruiting
A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients
NSCLC
PrincipalinvestigatorStart date: 2021-10-27
NCT04158440Phase 3Completed
Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC
Stage II-III Non-small Cell Lung Cancer
PrincipalinvestigatorStart date: 2020-04-07
NCT04477057Phase 1Unknown
Phaseâ… Study of the HS-10241 in Patients With Advanced Solid Tumors
Solid Tumor
PrincipalinvestigatorStart date: 2019-06-21
NCT03861156Phase 2Completed
D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer
EGFR T790MNSCLCSolid Tumor
StudychairStart date: 2019-02-28
Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB
Non Small Cell Lung Cancer
StudychairStart date: 2019-02-25

Research Network

Collaboration Network

7 collaborators·21 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xingya Li

The First Affiliated Hospital of Zhengzhou University

Related
2 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungSolid Tumor

Worked with same sponsors:

Jiangsu Hansoh Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score24%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungNSCLCSolid Tumor
Similarity Score15%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Solid TumorAdvanced Solid TumorCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Merck Sharp & Dohme LLC
Similarity Score15%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Advanced Solid TumorCarcinoma, Non-Small-Cell LungSolid Tumor
Similarity Score15%

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Solid TumorCarcinoma, Non-Small-Cell LungNSCLC
Similarity Score15%

Jason Wu

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Related
31 trials

Shared therapeutic areas:

Advanced Solid TumorSolid TumorCarcinoma, Non-Small-Cell Lung
Similarity Score15%

Shenglin Ma

First People's Hospital of Hangzhou

Related
2 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Jiangsu Hansoh Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Deguang Mu

Zhejiang Provincial People's Hospital

Related
1 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Jiangsu Hansoh Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

7Yubiao Guo

First Affiliated Hospital, Sun Yat-Sen University

Related
1 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Jiangsu Hansoh Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Xiaoju Zhang

Henan Provincial People's Hospital

Related
1 trials

Shared therapeutic areas:

Solid Tumor

Worked with same sponsors:

Jiangsu Hansoh Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT06373406Phase 1/2PrincipalInvestigator

A Study of MHB036C for Advanced Solid Tumor

Advanced Solid Tumor
Active Not Recruiting
NCT05078931Phase 2PrincipalInvestigator

A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients

NSCLC
Active Not Recruiting
NCT04158440Phase 3PrincipalInvestigator

Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC

Stage II-III Non-small Cell Lung Cancer
Completed
NCT04477057Phase 1PrincipalInvestigator

Phaseâ… Study of the HS-10241 in Patients With Advanced Solid Tumors

Solid Tumor
Unknown
NCT03861156Phase 2StudyChair

D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer

EGFR T790MNSCLCSolid Tumor
Completed
NCT04197076StudyChair

Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIB

Non Small Cell Lung Cancer
Unknown

All 6 trials loaded